Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Advanced Biomed Inc. (ADVB)

$18.98 +13.11% NASDAQ: ADVB · 15-min delayed
  • RENO, Nevada
  • Public · NASDAQ: ADVB
  • 31 employees
$6.9MMarket cap
-$3.3MNet income
31Employees
ADVBNASDAQ
2025IPO

About Advanced Biomed Inc.

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Net income
-$3.3M
Total assets
$6.5M
Market cap
$6.9M

Source: SEC EDGAR · updated Jun 7, 2026

FY 2025

Financial statements

Income statement

Operating expenses
$3.0M
Net income
-$3.3M
EPS (basic)
$-0.16
EPS (diluted)
$-0.16

Balance sheet

Total assets
$6.5M
Current assets
$6.0M
Total liabilities
$3.0M
Current liabilities
$2.9M
Shareholders’ equity
$3.5M

Cash flow

Operating cash flow
-$5.8M
Investing cash flow
-$31.6K
Financing cash flow
$5.9M
Net cash flow
$295.9K

Statements via Polygon.io (SEC filings)

NASDAQ: ADVB
$18.98 +13.11%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$3.71 $18.98

52-week range

Market cap
$6.9M
EPS (diluted)
$-0.16
Shares outstanding
363.0K
Open
Day range
Prev close
Volume
IPO date
Mar 6, 2025

Advanced Biomed Inc. (ADVB) Stock Price

  • Reported a net loss of $3.3M.
  • Trading near its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Advanced Biomed Inc..

Write a review
Newsroom

News about Advanced Biomed Inc.

News & sentiment via Polygon.io

FAQ

Advanced Biomed Inc.: frequently asked questions

Is Advanced Biomed Inc. an American company?

Advanced Biomed Inc. is a US-based company headquartered in Reno, Nevada, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Advanced Biomed Inc. headquartered?

Advanced Biomed Inc. is headquartered in Reno, Nevada, United States.

Is Advanced Biomed Inc. publicly traded?

Yes — Advanced Biomed Inc. is a publicly traded company. Its stock trades under the ticker symbol ADVB on the NASDAQ.

What does Advanced Biomed Inc. do?

Advanced Biomed Inc. is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →